Drug intelligence / Profile preview

Provella

Development stage: Unknown
Lead developer: Vertical Pharmaceuticals
Modality: Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
Administration: Oral

Overview

Provella is a probiotic dietary supplement developed by Vertical Pharmaceuticals specifically tailored for women's health. It contains a proprietary blend of six probiotic strains, including *Lactobacillus acidophilus* (La-14), *Lactobacillus rhamnosus* (HN001), *Lactobacillus gasseri* (Lg-36), *Bifidobacterium lactis* (Bi-07), *Bifidobacterium lactis* (Bl-04), and *Lactobacillus plantarum* (Lp-115). The supplement is designed to support digestive, vaginal, and immune health by restoring and maintaining a healthy balance of microflora, which can be disrupted by factors such as diet, stress, or the use of antibiotics. It is marketed as a once-daily oral capsule.

Brand names: Provella
Other names: Provella

Beyond the preview

Go deeper on Provella.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Provella.

Explore the full profile